Meet Geoffrey Parker, the Chief Financial Officer and Executive Vice President at Allogene Therapeutics. With a strong background in finance, he brings valuable experience to the company. Geoffrey graduated from Dartmouth College with a double major in Economics and Engineering...
Meet Geoffrey Parker, the Chief Financial Officer and Executive Vice President at Allogene Therapeutics. With a strong background in finance, he brings valuable experience to the company. Geoffrey graduated from Dartmouth College with a double major in Economics and Engineering Sciences and earned his MBA from Stanford. Before joining Allogene in 2023, he held key positions at Tricida, Inc. and Anacor Pharmaceuticals, the latter of which was acquired by Pfizer for around $5.2 billion. His previous role at Goldman Sachs involved leading the West Coast Healthcare Investment Banking group. In his new role at Allogene, Geoffrey is highly invested and has a significant compensation package, indicating strong trust in his leadership potential. His hands-on experience in the pharmaceutical industry and a solid educational foundation position him as an exciting figure within Allogene, especially as the company focuses on innovative treatments in the field of cell therapy.